Intellia Therapeutics (NTLA) PT Raised to $30 at Chardan Apr 27, 2026 02:50PM
Intellia Therapeutics (NTLA) PT Raised to $27 at Chardan Mar 2, 2026 02:18PM
Intellia Therapeutics to Present at October Healthcare Investor Conferences Sep 26, 2022 07:30AM
Intellia Therapeutics (NTLA) PT Lowered to $172 at Chardan Capital Markets Mar 1, 2022 07:53AM
Intellia Therapeutics to Present at Chardan’s 5th Annual Genetic Medicines Conference Sep 27, 2021 07:30AM


Jun 28, 2021 11:35AM Intellia Therapeutics (NTLA) PT Raised to $130 at Chardan Capital Markets
Feb 10, 2021 09:39AM Intellia Therapeutics (NTLA) PT Raised to $85 at Chardan Capital Markets
Sep 28, 2020 08:00AM Intellia Therapeutics to Present at Chardan’s Virtual 4th Annual Genetic Medicines Conference
Sep 30, 2019 08:00AM Intellia Therapeutics to Present at October Healthcare Investor Conferences
Sep 24, 2018 08:30AM Intellia Therapeutics to Present at October Healthcare Investor Conferences
May 15, 2018 09:20AM Pre-Open Movers 05/15: (XENE) (PFNX) (SORL) Higher; (VIPS) (MYE) (TSLA) Lower (more...)
May 15, 2018 07:06AM UPDATE: Chardan Capital Markets Upgrades Intellia Therapeutics (NTLA) to Buy
Oct 3, 2017 04:35PM Intellia Therapeutics to Present at October Healthcare Investor Conferences
Aug 29, 2017 09:33AM Pre-Open Movers 08/29: (MOV) (CTLT) (IMGN) Higher; (FINL) (ACOR) (JILL) Lower (more...)
Aug 29, 2017 03:20AM Chardan Capital Markets Downgrades Intellia Therapeutics (NTLA) to Neutral
Aug 2, 2017 06:56AM Intellia Therapeutics (NTLA): Raising PT - Chardan
Mar 27, 2017 04:30PM Chardan Capital Markets Starts Intellia Therapeutics (NTLA) at Buy